Serum GDF-15 marginally increases during rhEpo treatment. The serum levels of GDF-15 were determined by immunoradiometry. Values are mean plus or minus SE for 8 participants. The statistical differences from pre-rhEpo values were calculated with the Wilcoxon test; *P < .05.